Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Evolus, Inc.(EOLS) | 4,847,399 | 4,847,399 | 0 | $52.59M | $78.53M | 5.61% | +$25.93M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 2,254,797 | 2,254,797 | 0 | $61.29M | $74.16M | 5.30% | +$12.87M |
| Aurinia Pharmaceuticals Inc.(AUPH) | 2,779,500 | 7,229,500 | +4,450,000 | $15.87M | $52.99M | 3.79% | +$37.12M |
| Viridian Therapeutics, Inc.(VRDN) | 1,392,925 | 2,242,925 | +850,000 | $18.12M | $51.03M | 3.65% | +$32.90M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 1,287,107 | 1,287,107 | 0 | $44.01M | $50.20M | 3.59% | +$6.19M |
| Kalvista Pharmaceuticals Inc | 4,218,829 | 4,321,547 | +102,718 | $49.70M | $50.04M | 3.57% | +$345.7K |
| Anaptysbio Inc | 1,330,879 | 1,330,879 | 0 | $33.35M | $44.58M | 3.18% | +$11.23M |
| Immunocore Holdings plcADS(IMCR) | 405,600 | 1,105,600 | +700,000 | $13.75M | $34.42M | 2.46% | +$20.67M |
| Vaxcyte, Inc.(PCVX) | 300,000 | 300,000 | 0 | $22.65M | $34.28M | 2.45% | +$11.63M |
| BioNTech SEADS(BNTX) | 0 | 270,000 | +270,000 | $0 | $32.07M | 2.29% | +$32.07M |
| ANI Pharmaceuticals, Inc.(ANIP) | 450,000 | 450,000 | 0 | $28.66M | $26.85M | 1.92% | -$1.81M |
| PTC Therapeutics, Inc.(PTCT) | 700,000 | 700,000 | 0 | $21.41M | $25.97M | 1.86% | +$4.56M |
| Relay Therapeutics, Inc.(RLAY) | 0 | 3,568,058 | +3,568,058 | $0 | $25.26M | 1.80% | +$25.26M |
| Iteos Therapeutics Inc | 0 | 2,407,800 | +2,407,800 | $0 | $24.58M | 1.76% | +$24.58M |
| Applied Therapeutics Inc | 2,330,000 | 2,730,000 | +400,000 | $10.88M | $23.20M | 1.66% | +$12.32M |
| Acadia Pharmaceuticals Inc | 1,500,000 | 1,500,000 | 0 | $24.38M | $23.07M | 1.65% | -$1.30M |
| Intra-Cellular Therapies Inc | 300,000 | 300,000 | 0 | $20.55M | $21.95M | 1.57% | +$1.40M |
| Dynavax Technologies Corp | 2,500,000 | 1,900,000 | -600,000 | $28.07M | $21.17M | 1.51% | -$6.91M |
| Lakefront Biotherapeutics NVADR(LKFT) | 55,609 | 700,000 | +644,391 | $1.38M | $20.15M | 1.44% | +$18.78M |
| GSK plcADR(GSK) | 400,000 | 450,000 | +50,000 | $15.40M | $18.40M | 1.31% | +$3.00M |
| LENZ Therapeutics, Inc.(LENZ) | 747,616 | 766,940 | +19,324 | $12.93M | $18.21M | 1.30% | +$5.28M |
| NVIDIA Corporation(NVDA) | 115,019 | 147,732 | +32,713 | $14.21M | $17.94M | 1.28% | +$3.73M |
| Neurocrine Biosciences, Inc.(NBIX) | 0 | 150,000 | +150,000 | $0 | $17.28M | 1.23% | +$17.28M |
| Altimmune, Inc.(ALT) | 2,750,000 | 2,750,000 | 0 | $18.29M | $16.89M | 1.21% | -$1.40M |
| Avadel Pharmaceuticals Plc | 1,230,000 | 1,230,000 | 0 | $17.29M | $16.13M | 1.15% | -$1.16M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 625,309 | 628,609 | +3,300 | $11.67M | $15.71M | 1.12% | +$4.03M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 140,000 | 140,000 | 0 | $14.94M | $15.60M | 1.11% | +$655.2K |
| Atea Pharmaceuticals, Inc.(AVIR) | 4,476,741 | 4,607,060 | +130,319 | $14.82M | $15.43M | 1.10% | +$615.6K |
| Cullinan Therapeutics, Inc.(CGEM) | 921,138 | 921,138 | 0 | $16.06M | $15.42M | 1.10% | -$644.8K |
| Meta Platforms, Inc.CL A(META) | 11,396 | 25,855 | +14,459 | $5.75M | $14.80M | 1.06% | +$9.05M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 750,000 | 750,000 | 0 | $16.15M | $13.85M | 0.99% | -$2.29M |
| Zymeworks Inc.(ZYME) | 1,100,000 | 1,100,000 | 0 | $9.36M | $13.80M | 0.99% | +$4.44M |
| Replimune Group, Inc.(REPL) | 805,440 | 1,200,000 | +394,560 | $7.25M | $13.15M | 0.94% | +$5.90M |
| Revance Therapeutics Inc | 400,000 | 2,500,000 | +2,100,000 | $1.03M | $12.97M | 0.93% | +$11.95M |
| Cargo Therapeutics Inc | 572,697 | 700,749 | +128,052 | $9.40M | $12.93M | 0.92% | +$3.53M |
| Teladoc Health, Inc.(TDOC) | 1,000,000 | 1,400,000 | +400,000 | $9.78M | $12.85M | 0.92% | +$3.07M |
| Novavax, Inc.(NVAX) | 0 | 1,000,000 | +1,000,000 | $0 | $12.63M | 0.90% | +$12.63M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 316,500 | 266,500 | -50,000 | $17.09M | $12.52M | 0.89% | -$4.57M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 0 | 600,000 | +600,000 | $0 | $12.38M | 0.88% | +$12.38M |
| Adicet Bio Inc | 8,216,960 | 8,216,960 | 0 | $9.94M | $11.83M | 0.85% | +$1.89M |
| AstraZeneca PLCADR(AZN) | 150,000 | 150,000 | 0 | $11.70M | $11.69M | 0.83% | -$12.0K |
| Harmony Biosciences Holdings, Inc.(HRMY) | 281,200 | 281,200 | 0 | $8.48M | $11.25M | 0.80% | +$2.76M |
| Vanda Pharmaceuticals Inc.(VNDA) | 2,153,307 | 2,353,307 | +200,000 | $12.17M | $11.04M | 0.79% | -$1.13M |
| Immunome, Inc.(IMNM) | 720,000 | 720,000 | 0 | $8.71M | $10.53M | 0.75% | +$1.81M |
| CytomX Therapeutics, Inc.(CTMX) | 7,791,936 | 7,811,760 | +19,824 | $9.51M | $9.22M | 0.66% | -$288.3K |
| Nuvation Bio Inc.CL A(NUVB) | 3,751,864 | 3,900,000 | +148,136 | $10.96M | $8.93M | 0.64% | -$2.02M |
| Elanco Animal Health Incorporated(ELAN) | 0 | 600,000 | +600,000 | $0 | $8.81M | 0.63% | +$8.81M |
| Hillevax Inc | 0 | 4,920,000 | +4,920,000 | $0 | $8.66M | 0.62% | +$8.66M |
| Outlook Therapeutics, Inc.(OTLK) | 1,619,412 | 1,559,560 | -59,852 | $11.95M | $8.33M | 0.59% | -$3.62M |
| BeOne Medicines AGADR(ONC) | 37,000 | 37,000 | 0 | $5.28M | $8.31M | 0.59% | +$3.03M |
| Marinus Pharmaceuticals Inc | 4,800,000 | 4,700,000 | -100,000 | $5.62M | $8.27M | 0.59% | +$2.66M |
| Liquidia Corporation(LQDA) | 350,000 | 800,000 | +450,000 | $4.20M | $8.00M | 0.57% | +$3.80M |
| Design Therapeutics, Inc.(DSGN) | 1,480,975 | 1,480,975 | 0 | $4.96M | $7.97M | 0.57% | +$3.01M |
| ALX Oncology Holdings Inc.(ALXO) | 0 | 4,204,735 | +4,204,735 | $0 | $7.65M | 0.55% | +$7.65M |
| Viking Therapeutics, Inc.(VKTX) | 120,000 | 120,000 | 0 | $6.36M | $7.60M | 0.54% | +$1.24M |
| Insmed Incorporated(INSM) | 100,000 | 100,000 | 0 | $6.70M | $7.30M | 0.52% | +$600.0K |
| Dianthus Therapeutics, Inc.(DNTH) | 264,692 | 264,692 | 0 | $6.85M | $7.25M | 0.52% | +$397.0K |
| Biohaven Ltd.(BHVN) | 140,000 | 140,000 | 0 | $4.86M | $7.00M | 0.50% | +$2.14M |
| Biogen Inc.(BIIB) | 35,000 | 35,000 | 0 | $8.11M | $6.78M | 0.48% | -$1.33M |
| Ventyx Biosciences Inc | 3,100,000 | 3,100,000 | 0 | $7.16M | $6.76M | 0.48% | -$403.0K |
| Bausch Plus Lomb Corp | 0 | 350,000 | +350,000 | $0 | $6.75M | 0.48% | +$6.75M |
| Centessa Pharmaceuticals PlcADS | 0 | 400,000 | +400,000 | $0 | $6.40M | 0.46% | +$6.40M |
| Structure Therapeutics IncADS | 144,500 | 144,500 | 0 | $5.67M | $6.34M | 0.45% | +$667.6K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 800,000 | 800,000 | 0 | $4.94M | $6.08M | 0.43% | +$1.14M |
| Ionis Pharmaceuticals, Inc.(IONS) | 150,000 | 150,000 | 0 | $7.15M | $6.01M | 0.43% | -$1.14M |
| AbCellera Biologics Inc.(ABCL) | 461,699 | 2,300,000 | +1,838,301 | $1.37M | $5.98M | 0.43% | +$4.61M |
| Black Diamond Therapeutics I | 1,603,200 | 1,370,209 | -232,991 | $7.47M | $5.96M | 0.43% | -$1.51M |
| Apogee Therapeutics Inc | 100,000 | 100,000 | 0 | $3.94M | $5.87M | 0.42% | +$1.94M |
| Singular Genomics Systems In | 0 | 372,000 | +372,000 | $0 | $5.83M | 0.42% | +$5.83M |
| Precision BioSciences, Inc.(DTIL) | 623,332 | 623,332 | 0 | $6.07M | $5.59M | 0.40% | -$480.0K |
| Lantheus Holdings, Inc.(LNTH) | 50,000 | 50,000 | 0 | $4.01M | $5.49M | 0.39% | +$1.47M |
| Cytokinetics, Incorporated(CYTK) | 100,000 | 100,000 | 0 | $5.42M | $5.28M | 0.38% | -$138.0K |
| Nuvalent Inc | 0 | 50,000 | +50,000 | $0 | $5.12M | 0.37% | +$5.12M |
| Reneo Pharmaceuticals Inc | 2,996,260 | 2,946,260 | -50,000 | $4.52M | $5.01M | 0.36% | +$484.3K |
| Merus N V | 100,000 | 100,000 | 0 | $5.92M | $5.00M | 0.36% | -$921.0K |
| Alexandria Real Estate Eq In | 40,000 | 40,000 | 0 | $4.68M | $4.75M | 0.34% | +$71.2K |
| Iovance Biotherapeutics, Inc.(IOVA) | 500,000 | 500,000 | 0 | $4.01M | $4.70M | 0.34% | +$685.0K |
| Alumis Inc | 0 | 426,594 | +426,594 | $0 | $4.56M | 0.33% | +$4.56M |
| Seer, Inc.CL A(SEER) | 2,300,000 | 2,300,000 | 0 | $3.86M | $4.53M | 0.32% | +$667.0K |
| Arvinas, Inc.(ARVN) | 180,000 | 180,000 | 0 | $4.79M | $4.43M | 0.32% | -$358.2K |
| Beam Therapeutics Inc.(BEAM) | 270,000 | 170,000 | -100,000 | $6.33M | $4.17M | 0.30% | -$2.16M |
| SanofiADR(SNY) | 0 | 70,000 | +70,000 | $0 | $4.03M | 0.29% | +$4.03M |
| C4 Therapeutics, Inc.(CCCC) | 200,000 | 700,000 | +500,000 | $924.0K | $3.99M | 0.29% | +$3.07M |
| Heron Therapeutics, Inc.(HRTX) | 1,850,000 | 1,850,000 | 0 | $6.47M | $3.68M | 0.26% | -$2.79M |
| Cybin D/B/A Helus Pharma(HELP) | 0 | 400,000 | +400,000 | $0 | $3.56M | 0.25% | +$3.56M |
| Tyra Biosciences, Inc.(TYRA) | 42,223 | 150,000 | +107,777 | $675.1K | $3.53M | 0.25% | +$2.85M |
| Compass Therapeutics, Inc.(CMPX) | 0 | 1,812,995 | +1,812,995 | $0 | $3.34M | 0.24% | +$3.34M |
| Nkarta, Inc.(NKTX) | 550,000 | 650,000 | +100,000 | $3.25M | $2.94M | 0.21% | -$312.5K |
| Elevation Oncology Inc | 3,060,000 | 4,760,000 | +1,700,000 | $8.26M | $2.86M | 0.20% | -$5.41M |
| Kezar Life Sciences Inc | 0 | 3,640,300 | +3,640,300 | $0 | $2.81M | 0.20% | +$2.81M |
| Bolt Biotherapeutics Inc | 3,812,773 | 3,812,773 | 0 | $2.86M | $2.47M | 0.18% | -$388.9K |
| Fate Therapeutics, Inc.(FATE) | 700,000 | 700,000 | 0 | $2.30M | $2.45M | 0.18% | +$154.0K |
| Coherus Oncology, Inc.(CHRS) | 1,050,000 | 2,350,000 | +1,300,000 | $1.82M | $2.44M | 0.17% | +$627.5K |
| Genmab A/SADS(GMAB) | 100,000 | 100,000 | 0 | $2.51M | $2.44M | 0.17% | -$75.0K |
| Tectonic Therapeutic, Inc.(TECX) | 79,166 | 79,166 | 0 | $1.30M | $2.40M | 0.17% | +$1.09M |
| Springworks Therapeutics Inc | 0 | 74,265 | +74,265 | $0 | $2.38M | 0.17% | +$2.38M |
| TG Therapeutics, Inc.(TGTX) | 100,000 | 100,000 | 0 | $1.78M | $2.34M | 0.17% | +$560.0K |
| Theravance Biopharma Inc | 0 | 262,896 | +262,896 | $0 | $2.12M | 0.15% | +$2.12M |
| Kura Oncology, Inc.(KURA) | 100,000 | 100,000 | 0 | $2.06M | $1.95M | 0.14% | -$105.0K |
| Century Therapeutics, Inc.(IPSC) | 900,000 | 900,000 | 0 | $2.29M | $1.54M | 0.11% | -$756.0K |